Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Foxp3+ CD4+ T helper cells called regulatory T (T reg) cells play a key role in controlling reactivity to self-antigens and onset of autoimmunity. T reg cells either arise in thymus and are called natural T reg (nT reg) cells or are generated in the periphery through induction of Foxp3 and are called inducible T reg (iT reg) cells. The relative contributions of iT reg cells and nT reg cells in peripheral tolerance remain unclear as a result of an inability to separate these two subsets of T reg cells. Using a combination of novel TCR transgenic mice with a defined self-antigen specificity and conventional mouse models, we demonstrate that a cell surface molecule, neuropilin-1 (Nrp-1), is expressed at high levels on nT reg cells and can be used to separate nT reg versus iT reg cells in certain physiological settings. In addition, iT reg cells generated through antigen delivery or converted under homeostatic conditions lack Nrp-1 expression. Nrp-1lo iT reg cells show similar suppressive activity to nT reg cells in controlling ongoing autoimmune responses under homeostatic conditions. In contrast, their activity might be compromised in certain lymphopenic settings. Collectively, our data show that Nrp-1 provides an excellent marker to distinguish distinct T reg subsets and will be useful in studying the role of nT reg versus iT reg cells in different disease settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which distinguishes natural from induced Tregs in vivo.”
From Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells (2021) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699 · cited 1×
“…a phenotype distinct iT reg cells generated in vitro or in vivo lack Nrp-1 expression Stimulation of CD4+CD25 conventional T (T conv) cells with either antigen-loaded APCs or anti-CD3 plus antiCD28 beads in the presence of TGF- results in the induction of Foxp3+ T reg cells (Chen et al., 2003).”
BackgroundBennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402 · cited 1×
“2012 Vol. 209 No. 10 1713-1722 www.jem.org/cgi/doi/10.1084/jem.20120822 1713 Brief Definit ive Report Foxp3+ regulatory T (T reg) cells constitute a population of CD4+ T cells that plays a key role in maintaining immune homeostasis and tolerance (Bennett et al., 2001).”
BackgroundInfluentialThornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382 · cited 4×
“Nearly 70% of Foxp3+ T reg cells expressed Nrp-1 in WT NOD or B6 mice correlating with Helios expression (Fig. 2 c; Thornton et al., 2010), suggesting that Nrp-1hi T reg cells were thymically derived, whereas Nrp-1lo T reg cells represented a Figure 1.”
BackgroundInfluentialZhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1774 · Cited by 1,370 · cited 2×
“Foxp3-GFP-Cre reporter mice have been previously described (Louvet et al., 2009; Zhou et al., 2009).”
MethodSelf-citationNatural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323 · cited 1×
“Foxp3+ T reg cells arise both in the thymus (natural T reg [nT reg] cells) and in the periphery (inducible T reg [iT reg] cells) as a consequence of exposure to antigens (Bluestone and Abbas, 2003).”
BackgroundSelf-citationEpigenetic Control of the foxp3 Locus in Regulatory T Cells
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.-D., Bopp, T., Schmitt, E., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050038 · Cited by 1,270 · cited 1×
“A quantitative real-time PCR method was developed to analyze the methylation status of key CpG dinucleotides in the TSDR of the FOXP3 gene where demethylation has been shown to correlate with stable T reg cells (Floess et al., 2007).”
MethodIn Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221 · cited 4×
“RAG/ mice before the disease onset (Tang et al., 2004).”
MethodInfluentialSelf-citationCutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927 · cited 2×
“have been shown to be protective in some studies (Mottet et al., 2003; Huter et al., 2008; Haribhai et al., 2011) although others have reported less efficacy (Hill et al.”
ResultDNA methylation controls Foxp3 gene expression
Polansky, J. K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., Olek, S., Hamann, A., von Boehmer, H., & Huehn, J. (2008) · European Journal of Immunology · doi:10.1002/eji.200838105 · Cited by 785 · cited 3×
“Importantly, unlike in the in vitro induced cells, in vivo generated iT reg cells exhibited a demethylated Foxp3 T reg cell–specific demethylation region (TSDR; Polansky et al., 2008).”
BackgroundInfluentialIn Vivo Instruction of Suppressor Commitment in Naive T Cells
Apostolou, I., & von Boehmer, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040249 · Cited by 728
Cited by
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Lindau, D., Gielen, P., Kroesen, M., Wesseling, P., & Adema, G. J. (2013) · Immunology · doi:10.1111/imm.12036 · Cited by 815
Treg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Self-citationthe Immunological Genome Consortium, Robinette, M. L., Fuchs, A., Cortez, V. S., Lee, J. S., Wang, Y., Durum, S. K., Gilfillan, S., & Colonna, M. (2015) · Nature Immunology · doi:10.1038/ni.3094 · Cited by 641
tTregs, pTregs, and iTregs: similarities and differences
Shevach, E. M., & Thornton, A. M. (2014) · Immunological Reviews · doi:10.1111/imr.12160 · Cited by 606
“Two recent reports (61, 62) have claimed that the cell surface antigen neuropilin 1 (Nrp1) distinguishes tTregs from pTregs or iTregs.”
BackgroundFetomaternal immune cross-talk and its consequences for maternal and offspring's health
Arck, P. C., & Hecher, K. (2013) · Nature Medicine · doi:10.1038/nm.3160 · Cited by 600
Persson, E. K., Uronen-Hansson, H., Semmrich, M., Rivollier, A., Hägerbrand, K., Marsal, J., Gudjonsson, S., Håkansson, U., Reizis, B., Kotarsky, K., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.009 · Cited by 588
Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
Delgoffe, G. M., Woo, S.-R., Turnis, M. E., Gravano, D. M., Guy, C., Overacre, A. E., Bettini, M. L., Vogel, P., Finkelstein, D., Bonnevier, J., et al. (2013) · Nature · doi:10.1038/nature12428 · Cited by 587
Development and maintenance of intestinal regulatory T cells
Tanoue, T., Atarashi, K., & Honda, K. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.36 · Cited by 553
c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
Xu, M., Pokrovskii, M., Ding, Y., Yi, R., Au, C., Harrison, O. J., Galan, C., Belkaid, Y., Bonneau, R., & Littman, D. R. (2018) · Nature · doi:10.1038/nature25500 · Cited by 498
Homeostatic control of regulatory T cell diversity
Liston, A., & Gray, D. H. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3605 · Cited by 427
CD4 + T-cell subsets in inflammatory diseases: beyond the T h 1/T h 2 paradigm
Hirahara, K., & Nakayama, T. (2016) · International Immunology · doi:10.1093/intimm/dxw006 · Cited by 417
Smigiel, K. S., Richards, E., Srivastava, S., Thomas, K. R., Dudda, J. C., Klonowski, K. D., & Campbell, D. J. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131142 · Cited by 405
“In contrast, expression of the transcription factor Helios, which, along with Neuropilin-1, is preferentially expressed by thymus-derived T reg cells (Thornton et al., 2010; Yadav et al., 2012), was identical in cTR and eTR cells (Fig.”
BackgroundTreg Heterogeneity, Function, and Homeostasis
Shevyrev, D., & Tereshchenko, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03100 · Cited by 404
Bailey-Bucktrout, S. L., Martinez-Llordella, M., Zhou, X., Anthony, B., Rosenthal, W., Luche, H., Fehling, H. J., & Bluestone, J. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.016 · Cited by 396
“I unstable for Foxp3 expression and suppressor activity (Chen et al., 2011; Josefowicz et al., 2012; Yadav et al., 2012).”
BackgroundMethodSelf-citationMicrobiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy
Abdel-Gadir, A., Stephen-Victor, E., Gerber, G. K., Noval Rivas, M., Wang, S., Harb, H., Wang, L., Li, N., Crestani, E., Spielman, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0461-z · Cited by 390
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
Kitagawa, Y., Ohkura, N., Kidani, Y., Vandenbon, A., Hirota, K., Kawakami, R., Yasuda, K., Motooka, D., Nakamura, S., Kondo, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3646 · Cited by 379
Regulatory T cells in allergic diseases
Noval Rivas, M., & Chatila, T. A. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.003 · Cited by 373
CD4 T Helper Cell Subsets and Related Human Immunological Disorders
Zhu, X., & Zhu, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218011 · Cited by 373
“Several markers, including Helios and neuropilin (Nrp), have been proposed to distinguish pTreg cells from tTreg cells [179,180]; however, these molecules can also be expressed by some pTreg cells, indicating that they may simply mark more differentiated Treg cells.”
BackgroundFaith, J. J., Ahern, P. P., Ridaura, V. K., Cheng, J., & Gordon, J. I. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008051 · Cited by 373
“To determine whether the observed increases in Tregs represented accumulation of pTregs or tTregs, we assayed expression of neuropilin-1 (Nrp1) in FoxP3 Tregs [tTregs are Nrp1 , whereas pTregs are Nrp1 lo/− (38, 39)].”
MethodRegulation of Adaptive Immunity; The Role of Interleukin-10
Ng, T. H. S., Britton, G. J., Hill, E. V., Verhagen, J., Burton, B. R., & Wraith, D. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00129 · Cited by 354
“Although several groups have attempted to define a phenotype which distinguishes tTreg and pTreg (Thornton et al., 2010; Weiss et al., 2012; Yadav et al., 2012), at the time of writing, no molecular markers have been identified that can adequately discriminate these two types of Foxp3+ Treg cells,…”
BackgroundMemory regulatory T cells reside in human skin
Sanchez Rodriguez, R., Pauli, M. L., Neuhaus, I. M., Yu, S. S., Arron, S. T., Harris, H. W., Yang, S. H.-Y., Anthony, B. A., Sverdrup, F. M., Krow-Lucal, E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72932 · Cited by 354
“Multiplex quantitative PCR was used to analyze the methylation status of specific CpG dinucleotides in the TSDR region of the human FOXP3 gene as described previously (37).”
Self-citationGalectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
Wu, C., Thalhamer, T., Franca, R. F., Xiao, S., Wang, C., Hotta, C., Zhu, C., Hirashima, M., Anderson, A. C., & Kuchroo, V. K. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.011 · Cited by 349
DuPage, M., Chopra, G., Quiros, J., Rosenthal, W. L., Morar, M. M., Holohan, D., Zhang, R., Turka, L., Marson, A., & Bluestone, J. A. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.007 · Cited by 332
“The GFP+RFPneg cells were CD25+, Nrp-1+, and more naive (CD44lo CD62Lhi) than GFP+RFP+ cells, which suggests committed Treg cells of thymic origin (Figures S4D and S4E) (Miyao et al., 2012; Weiss et al., 2012; Yadav et al., 2012).”
Self-citationAire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
Malchow, S., Leventhal, D. S., Nishi, S., Fischer, B. I., Shen, L., Paner, G. P., Amit, A. S., Kang, C., Geddes, J. E., Allison, J. P., et al. (2013) · Science · doi:10.1126/science.1233913 · Cited by 328
Savage, P. A., Klawon, D. E. J., & Miller, C. H. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100219-020937 · Cited by 321
“Initial reports suggested that the transcription factor Helios (173) and cell surface receptor Neuropilin-1 (174, 175) are uniquely expressed by tTreg cells, but subsequent reports demonstrated that these markers can also be expressed by pTreg cells or in vitro–differentiated Treg cells in some instances (176–180).”
BackgroundSun, J., Furio, L., Mecheri, R., van der Does, A. M., Lundeberg, E., Saveanu, L., Chen, Y., van Endert, P., Agerberth, B., & Diana, J. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.013 · Cited by 292
FOXP3+ regulatory T cells and their functional regulation
Li, Z., Li, D., Tsun, A., & Li, B. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.10 · Cited by 290
Boyd, A., Zhang, H., & Williams, A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1112-y · Cited by 287
“The receptor for Sema3A is NP1, which is a transmembrane receptor present on OPCs, but also on macrophage/microglia [28] and T-regulatory cells (Treg) [53, 56].”
BackgroundRole of regulatory T cells in psoriasis pathogenesis and treatment
Nussbaum, L., Chen, Y. L., & Ogg, G. S. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19380 · Cited by 279
Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
Yadav, M., Stephan, S., & Bluestone, J. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00232 · Cited by 273
“CD28−/− mice, which have a greatly reduced number of tTregs (30).”
BackgroundInfluentialSelf-citationFunction of a Foxp3 cis -Element in Protecting Regulatory T Cell Identity
Li, X., Liang, Y., LeBlanc, M., Benner, C., & Zheng, Y. (2014) · Cell · doi:10.1016/j.cell.2014.07.030 · Cited by 270
“We also took advantage of Neuropilin 1 (Nrp1) as a marker for natural Tregs (nTregs) to sort both nTregs (Nrp1) and iTregs (Nrp1) from unprovoked Foxp3 and CNS2 mice to test their lineage stability (Figure S5E) (Weiss et al., 2012; Yadav et al., 2012).”
Adaptive immune education by gut microbiota antigens
Zhao, Q., & Elson, C. O. (2018) · Immunology · doi:10.1111/imm.12896 · Cited by 268
Zebrafish Regulatory T Cells Mediate Organ-Specific Regenerative Programs
Hui, S. P., Sheng, D. Z., Sugimoto, K., Gonzalez-Rajal, A., Nakagawa, S., Hesselson, D., & Kikuchi, K. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.11.010 · Cited by 264
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
Sharma, A., & Rudra, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00883 · Cited by 262
“Other than the specific TCR repertoire, high surface expression of Helios, an Ikaros family transcription factor (115), and Nrp1, a membrane-bound co-receptor for vascular endothelial growth factor and semaphorin (116, 117), has been found to be associated with tTregs.”
BackgroundCD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors
Kalekar, L. A., Schmiel, S. E., Nandiwada, S. L., Lam, W. Y., Barsness, L. O., Zhang, N., Stritesky, G. L., Malhotra, D., Pauken, K. E., Linehan, J. L., et al. (2016) · Nature Immunology · doi:10.1038/ni.3331 · Cited by 260
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression
Sharma, M., Schlegel, M. P., Afonso, M. S., Brown, E. J., Rahman, K., Weinstock, A., Sansbury, B. E., Corr, E. M., van Solingen, C., Koelwyn, G. J., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316461 · Cited by 259
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Paluskievicz, C. M., Cao, X., Abdi, R., Zheng, P., Liu, Y., & Bromberg, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02453 · Cited by 251
“Neuropilin-1 (Nrp-1), a semaphorin III receptor, serves as a transmembrane glycoprotein for isoforms of vascular endothelial growth factors (VEGFs), endothelial growth factors, and transforming growth factor beta (TGFβ) (6).”
BackgroundNatural and Induced T Regulatory Cells in Cancer
Adeegbe, D. O., & Nishikawa, H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00190 · Cited by 248
“NEUROPILIN-1 Neuropilin-1 (Nrp-1), a type-1 transmembrane protein is yet another molecule that is being implicated in the iTreg versus nTreg identification issue (43, 49, 50).”
BackgroundHalim, T. Y. F., Rana, B. M. J., Walker, J. A., Kerscher, B., Knolle, M. D., Jolin, H. E., Serrao, E. M., Haim-Vilmovsky, L., Teichmann, S. A., Rodewald, H.-R., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.003 · Cited by 249
“GATA3 Treg cells in control (PBS), papain-, or IL-33-exposed lungs were likely thymus derived, as indicated by co-expression of the transcription factor Helios and the vascular endothelial growth factor (VEGF) co-receptor neuropillin (Nrp)-1 (Figures 1A, 1B, and S1E; Thornton et al., 2010; Yadav et al., 2012).”
BackgroundSawant, D. V., & Vignali, D. A. A. (2014) · Immunological Reviews · doi:10.1111/imr.12173 · Cited by 245
“During the inflammatory autoimmune response in the CNS, a significant percentage of antigenspecific Tregs exhibiting the canonical Treg signature (CD25hi Foxp3hi, demethylated TSDR) downregulated Foxp3 at both the transcript and protein level and acquired effector characteristics (production of IFNc and pathogenic pot…”
BackgroundMethodInfluentialOxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
Clever, D., Roychoudhuri, R., Constantinides, M. G., Askenase, M. H., Sukumar, M., Klebanoff, C. A., Eil, R. L., Hickman, H. D., Yu, Z., Pan, J. H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.032 · Cited by 242
“Neuropilin-1 (Nrp-1) has been proposed as a marker to distinguish tTreg cells from iTreg cells (Weiss et al., 2012; Yadav et al., 2012).”
BackgroundRegulatory T Cells: the Many Faces of Foxp3
Georgiev, P., Charbonnier, L.-M., & Chatila, T. A. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00684-7 · Cited by 241
Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy
Roy, S., Bag, A. K., Singh, R. K., Talmadge, J. E., Batra, S. K., & Datta, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01228 · Cited by 240
“Several papers reported high NRP1 expression on nTregs compared with iTregs (195, 196) and a correlation of NRP1 expression with Helios on Foxp3+ Treg population(s).”
ResultLegoux, F. P., Lim, J.-B., Cauley, A. W., Dikiy, S., Ertelt, J., Mariani, T. J., Sparwasser, T., Way, S. S., & Moon, J. J. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.011 · Cited by 238
“Cre:I-Ab-specific Foxp3+ Tregs in our mice uniformly expressed both Helios and Neuropilin-1, which was consistent with a tTreg phenotype (Figure S5A) (Thornton et al., 2010; Yadav et al., 2012).”
Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa
Pandiyan, P., Bhaskaran, N., Zou, M., Schneider, E., Jayaraman, S., & Huehn, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00426 · Cited by 236
Neuropilin 1: function and therapeutic potential in cancer
Chaudhary, B., Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1500-0 · Cited by 233
“[60] generated pTregs via: (1) stimulation of conventional CD4+ cells in vitro with TGF-β and CD3/CD28 microbeads or Ag-primed antigen presenting cells (APCs), (2) in vivo homeostatic conversion of naïve T cells transplanted into the RAG-deficient mice and (3) prolonged in vivo sub-immunogenic stimulation of ovalbumin…”
BackgroundMethodResultInfluentialRole of regulatory T cells during virus infection
Veiga‐Parga, T., Sehrawat, S., & Rouse, B. T. (2013) · Immunological Reviews · doi:10.1111/imr.12085 · Cited by 232
Generation and Function of Induced Regulatory T Cells
Schmitt, E. G., & Williams, C. B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00152 · Cited by 229
CD 4+ T‐cell subsets in intestinal inflammation
Shale, M., Schiering, C., & Powrie, F. (2013) · Immunological Reviews · doi:10.1111/imr.12039 · Cited by 224
Lu, L., Lan, Q., Li, Z., Zhou, X., Gu, J., Li, Q., Wang, J., Chen, M., Liu, Y., Shen, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408780111 · Cited by 225
Immunological functions of the neuropilins and plexins as receptors for semaphorins
Kumanogoh, A., & Kikutani, H. (2013) · Nature Reviews Immunology · doi:10.1038/nri3545 · Cited by 224
TREG-cell therapies for autoimmune rheumatic diseases
Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 214
Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity
Shi, H., & Chi, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02716 · Cited by 202
Functional and phenotypic heterogeneity of group 3 innate lymphoid cells
Melo‐Gonzalez, F., & Hepworth, M. R. (2017) · Immunology · doi:10.1111/imm.12697 · Cited by 199
mTOR signaling in the differentiation and function of regulatory and effector T cells
Zeng, H., & Chi, H. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.005 · Cited by 198
Kashiwagi, I., Morita, R., Schichita, T., Komai, K., Saeki, K., Matsumoto, M., Takeda, K., Nomura, M., Hayashi, A., Kanai, T., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.010 · Cited by 193
Chapman, N. M., Zeng, H., Nguyen, T.-L. M., Wang, Y., Vogel, P., Dhungana, Y., Liu, X., Neale, G., Locasale, J. W., & Chi, H. (2018) · Nature Communications · doi:10.1038/s41467-018-04392-5 · Cited by 192
Regulation of Treg cells by cytokine signaling and co-stimulatory molecules
Zong, Y., Deng, K., & Chong, W. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387975 · Cited by 183
Aloulou, M., Carr, E. J., Gador, M., Bignon, A., Liblau, R. S., Fazilleau, N., & Linterman, M. A. (2016) · Nature Communications · doi:10.1038/ncomms10579 · Cited by 190
Modulation of regulatory T cell function and stability by co-inhibitory receptors
Lucca, L. E., & Dominguez-Villar, M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0296-3 · Cited by 189
Obata, Y., Furusawa, Y., Endo, T. A., Sharif, J., Takahashi, D., Atarashi, K., Nakayama, M., Onawa, S., Fujimura, Y., Takahashi, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2886 · Cited by 178
Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo
Durham, N. M., Nirschl, C. J., Jackson, C. M., Elias, J., Kochel, C. M., Anders, R. A., & Drake, C. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109080 · Cited by 178
“Additionally, these cells expressed similar amounts of other Treg markers such as Helios, GITR [40,41], and NRP-1 [42–45] (Figure S1C).”
BackgroundInduced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
Mayne, C. G., & Williams, C. B. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f5a3 · Cited by 178
“Nrp-1 expression differences are largely maintained, even when cells are activated.(63,64) Conversely, iTreg cells differentiated under inflammatory conditions in the lung or central nervous system seem to gain Nrp-1 expression.”
BackgroundMassoud, A. H., Charbonnier, L.-M., Lopez, D., Pellegrini, M., Phipatanakul, W., & Chatila, T. A. (2016) · Nature Medicine · doi:10.1038/nm.4147 · Cited by 177
“To determine the impact of IL-4 signaling on Il4ra R576 nT reg cells, splenic Nrp1 high WT and Il4ra R576 T reg cells, which are overwhelmingly nT reg cells 29,30 , were isolated to high purity by cell sorting ( Supplementary Fig.”
The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells
Ye, J., Qiu, J., Bostick, J. W., Ueda, A., Schjerven, H., Li, S., Jobin, C., Chen, Z.-M. E., & Zhou, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.114 · Cited by 175
“Nrp1 has been suggested as a surface marker to distinguish thymus-derived Tregs (Nrp1+ tTregs) versus peripherally derived Tregs (Nrp1– pTregs) (Weiss et al., 2012; Yadav et al., 2012).”
BackgroundInfluentialImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
Perng, P., & Lim, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00153 · Cited by 166
Szurek, E., Cebula, A., Wojciech, L., Pietrzak, M., Rempala, G., Kisielow, P., & Ignatowicz, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141161 · Cited by 163
“Neuropilin-1 (Nrp-1) is another molecule that was reported to be expressed at high levels on mouse tTregs but not on pTregs [25, 26].”
BackgroundMechanisms underlying helper T-cell plasticity: Implications for immune-mediated disease
Hirahara, K., Poholek, A., Vahedi, G., Laurence, A., Kanno, Y., Milner, J. D., & O’Shea, J. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.015 · Cited by 161
CNS Repair Requires Both Effector and Regulatory T Cells with Distinct Temporal and Spatial Profiles
Raposo, C., Graubardt, N., Cohen, M., Eitan, C., London, A., Berkutzki, T., & Schwartz, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0076-14.2014 · Cited by 161
“To address whether the Tregs were recruited from the periphery or were the outcome of a local conversion from effector T cells, we measured the levels of Neuropilin-1 (Nrp1), the expression of which is known to be associated with the thymus-derived Treg subset, but not with the inducible Tregs (Weiss et al., 2012; Yad…”
BackgroundSchaer, D. A., Budhu, S., Liu, C., Bryson, C., Malandro, N., Cohen, A., Zhong, H., Yang, X., Houghton, A. N., Merghoub, T., et al. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0086 · Cited by 160
Loss of TET2 and TET3 in regulatory T cells unleashes effector function
Yue, X., Lio, C.-W. J., Samaniego-Castruita, D., Li, X., & Rao, A. (2019) · Nature Communications · doi:10.1038/s41467-019-09541-y · Cited by 160
Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential
Wang, L., Liang, Y., Zhao, C., Ma, P., Zeng, S., Ju, D., Zhao, M., Yu, M., & Shi, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02326-4 · Cited by 207
“55,56 Therefore, Helios and NRP1 are often used to separate tTreg cells from pTreg cells in certain physiological settings.”
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
Leclerc, M., Voilin, E., Gros, G., Corgnac, S., de Montpréville, V., Validire, P., Bismuth, G., & Mami‐Chouaib, F. (2019) · Nature Communications · doi:10.1038/s41467-019-11280-z · Cited by 155
T cells in the control of organ-specific autoimmunity
Bluestone, J. A., Bour-Jordan, H., Cheng, M., & Anderson, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78089 · Cited by 155
“Conversely, pTregs are capable of controlling islet-specific but not CNS-specific autoreactive T cells, while tTregs can control both (96).”
BackgroundSelf-citationFOXP3+ Treg Cells and Gender Bias in Autoimmune Diseases
Nie, J., Li, Y. Y., Zheng, S. G., Tsun, A., & Li, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00493 · Cited by 169
“Other studies have identified Neuropilin 1 (NRP1) specifically and highly expressed on tTreg cells but not pTreg cells (55), and glycoprotein A repetitions predominant (GARP) expressed on activated human tTreg cells but not TGFβ-induced iTreg cells (56), but subsequent reports found that NRP1low pTreg cells could be c…”
BackgroundmTOR Signaling, Tregs and Immune Modulation
Chapman, N. M., & Chi, H. (2014) · Immunotherapy · doi:10.2217/imt.14.84 · Cited by 148
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Chuckran, C. A., Liu, C., Bruno, T. C., Workman, C. J., & Vignali, D. A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000967 · Cited by 147
Rapid and Efficient Generation of Regulatory T Cells to Commensal Antigens in the Periphery
Nutsch, K., Chai, J. N., Ai, T. L., Russler-Germain, E. V., Feehley, T., Nagler‐Anderson, C., & Hsieh, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.092 · Cited by 156
“To determine whether the timing of Treg cell selection seen with CT2/CT6 is representative of a polyclonal population, we used Helios and Nrp-1, which have been reported to mark tTreg cells (Weiss et al., 2012; Yadav et al., 2012).”
Differential Roles of IL-2 Signaling in Developing versus Mature Tregs
Fan, M. Y., Low, J. S., Tanimine, N., Finn, K. K., Priyadharshini, B., Germana, S. K., Kaech, S. M., & Turka, L. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.002 · Cited by 157
Advances in distinguishing natural from induced Foxp3(+) regulatory T cells.
Lin, X.-H., Chen, M., Liu, Y., Guo, Z., He, X., Brand, D. D., & Zheng, S. G. (2013) · PubMed Central · Cited by 139
Bereshchenko, O., Coppo, M., Bruscoli, S., Biagioli, M., Cimino, M., Frammartino, T., Sorcini, D., Venanzi, A., Di Sante, M., & Riccardi, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.004 · Cited by 131
“Gray lines show fluorescence-minusone (FMO) controls for Nrp-1 staining.”
BackgroundResultInfluentialOpportunities for Treg cell therapy for the treatment of human disease
Bluestone, J. A., McKenzie, B. S., Beilke, J. N., & Ramsdell, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166135 · Cited by 154
“In fact, the literature suggests that the majority of “unstable” Tregs are likely derived from induced peripheral Tregs, generated in the periphery in vivo upon encounter with TGFb and other Treg-promoting cytokines (19, 22).”
BackgroundSelf-citationTranscriptional regulation and development of regulatory T cells
Lee, W., & Lee, G. R. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.313 · Cited by 164
Treg therapy in transplantation: a general overview
Romano, M., Tung, S. L., Smyth, L. A., & Lombardi, G. (2016) · Transplant International · doi:10.1111/tri.12909 · Cited by 153
“(pTregs) [33,34] in human, this is not possible [35].”
BackgroundThe Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
Jørgensen, N., Persson, G., & Hviid, T. V. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00911 · Cited by 149
“Both tymus-derived tTregs and peripheral iTregs are characterized by high expression of CD25, FoxP3, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and glucocorticoid-induced tumor necrosis factor-related receptor (GITR), but iTregs have been shown to express reduced levels of programmed cell death protein 1 (P…”
BackgroundRegulatory T Cells and Immune Tolerance in the Intestine
Harrison, O. B., & Powrie, F. M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018341 · Cited by 139
“In the absence of inflammation, the use of neuropilin-1 (Nrp-1) as a selective marker of tTreg appears promising; mucosa-derived iTreg are Nrp-1 compared with their tTreg Nrp-1 counterparts (Weiss et al. 2012; Yadav et al. 2012).”
BackgroundAlloimmunity and Tolerance in Corneal Transplantation
Amouzegar, A., Chauhan, S. K., & Dana, R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600251 · Cited by 141
“and not on peripherally induced Tregs, was used to further determine the lineage of these exTregs (121).”
MethodAlunno, A., Manetti, M., Caterbi, S., Ibba‐Manneschi, L., Bistoni, O., Bartoloni, E., Valentini, V., Terenzi, R., & Gerli, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/751793 · Cited by 149
“In addition, other surface markers that allow the distinguishing of different subsets of natural and induced Treg cells, such as Neuropilin-1 [30] or Helios [31], have not been investigated in RA.”
BackgroundScurr, M. J., Ladell, K., Besneux, M., Christian, A. D., Hockey, T., Smart, K., Bridgeman, H. M., Hargest, R., Phillips, S. M., Davies, M. M., et al. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.62 · Cited by 142
“19 In order to verify these findings, we attempted to stain samples with Neuropilin-1, another marker that was recently postulated to be selectively expressed on naturally occurring Tregs; 25 however, we failed to detect any Neuorpilin-1 þ CD4 þ T cells withinthecolonorcolorectaltumors( SupplementaryFigureS2 ).”
Impact of Immune-Modulatory Drugs on Regulatory T Cell
Furukawa, A., Wisel, S. A., & Tang, Q. (2016) · Transplantation · doi:10.1097/tp.0000000000001379 · Cited by 137
Regulatory T Cell Plasticity and Stability and Autoimmune Diseases
Qiu, R., Zhou, L., Ma, Y., Zhou, L., Liang, T., Shi, L., Long, J., & Yuan, D. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8721-0 · Cited by 140
Regulatory T cells in the face of the intestinal microbiota
Ramanan, D., Pratama, A., Zhu, Y., Venezia, O., Sassone-Corsi, M., Chowdhary, K., Galván-Peña, S., Sefik, E., Brown, C., Gélineau, A., et al. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00890-w · Cited by 126
“43,112 ), proved to be incompletely reliable 113 , as both can by upregulated by TCR-driven activation 114–116 .”
BackgroundShikhagaie, M., Björklund, Å. K., Mjösberg, J., Erjefalt, J. S., Cornelissen, A. S., Ros, X. R., Bal, S. M., Koning, J. J., Mebius, R. E., Mori, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.063 · Cited by 130
Immunological GABAergic interactions and therapeutic applications in autoimmune diseases
Prud’homme, G. J., Glinka, Y., & Wang, Q. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.011 · Cited by 132
“Of importance, GABA increased Tregs of the Foxp3+/neuropilin-1+ phenotype [11], which have been shown to be mainly of the thymusderived type (tTreg) [48,49].”
BackgroundThelemann, C., Eren, R. O., Coutaz, M., Brasseit, J., Bouzourène, H., Rosa, M., Duval, A., Lavanchy, C., Mack, V., Mueller, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086844 · Cited by 122
“majority of colonic Treg cells were generated peripherally [33].”
BackgroundSmigielska‐Czepiel, K., van den Berg, A., Jellema, P. G., Lei, R., Bijzet, J., Kluiver, J. L., Boots, A. M. H., Brouwer, E., & Kroesen, B. J. (2014) · Genes and Immunity · doi:10.1038/gene.2013.69 · Cited by 133
Zhang, X., Xiao, X., Lan, P., Li, J., Dou, Y., Chen, W., Ishii, N., Chen, S., Xia, B., Chen, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.052 · Cited by 134
Organ-Specific and Memory Treg Cells: Specificity, Development, Function, and Maintenance
Gratz, I. K., & Campbell, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00333 · Cited by 136
Nakajima, A., Kaga, N., Nakanishi, Y., Ohno, H., Miyamoto, J., Kimura, I., Hori, S., Sasaki, T., Hiramatsu, K., Okumura, K., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700248 · Cited by 125
Metadata
- Authors
- Yadav, M., Louvet, C., Davini, D., Gardner, J. M., Martinez-Llordella, M., Bailey-Bucktrout, S., Anthony, B. A., Sverdrup, F. M., Head, R., Kuster, D. J., Ruminski, P., Weiss, D., Von Schack, D., & Bluestone, J. A.
- Affiliations
- University of California, San Francisco (US)
- Diabetes Center 1 and 2
- Saint Louis University (US)
- Pfizer (United States) (US)
- Inflammation and Immunology Research Unit, Pfizer Biotherapeutics Research and Development, Cambridge, MA 02140 4
- Corresponding author
- Bluestone, Jeffrey A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-09-10
- Volume
- 209
- Issue
- 10
- Pages
- 1713-1722
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3457729
- OpenAlex
- W2112498628
- Cited by
- 649
- References
- 33
- Citations by year
- 2026: 16 · 2025: 14 · 2024: 24 · 2023: 24 · 2022: 40 · 2021: 44 · 2020: 39 · 2019: 57 · 2018: 51 · 2017: 55 · 2016: 73 · 2015: 66 · 2014: 78 · 2013: 61 · 2012: 6
- FWCI
- 29.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI50834, R01AI046643, R01AI050834)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK-63720, P30DK063720)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- neuropilin-1, regulatory T cells, natural regulatory T cells, inducible regulatory T cells, Foxp3, T cell subsets, TCR transgenic mice, autoimmune disease, peripheral tolerance, lymphopenia, cell surface markers
- MeSH terms
- Animals, Myelin Basic Protein, Gene Expression Regulation, Lymphocyte Activation, Lymphoid Tissue, Male, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Antigen, T-Cell, Autoimmunity, T-Lymphocyte Subsets, Mice, Inbred NOD, Neuropilin-1, T-Lymphocytes, Regulatory, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.